vimarsana.com

Latest Breaking News On - J pediatr otorhinolaryngol - Page 1 : vimarsana.com

Persistent obstructive sleep apnoea in children: treatment options and management considerations

Unresolved obstructive sleep apnoea (OSA) after an adenotonsillectomy, henceforth referred to as persistent OSA, is increasingly recognised in children (2–18 years). Although associated with obesity, underlying medical complexity, and craniofacial disorders, persistent OSA also occurs in otherwise healthy children. Inadequate treatment of persistent OSA can lead to long-term adverse health outcomes beyond childhood. Positive airway pressure, used as a one-size-fits-all primary management strategy for persistent childhood OSA, is highly efficacious but has unacceptably low adherence rates.

MED-EL Presents: World Cochlear Implant Day 2023 - Over 45 years of major technological advances that enhance hearing and quality of life

Stat Consult: Foreign Body Aspiration

This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of foreign body aspiration.

Frontiers | Concurrent Newborn Hearing and Genetic Screening in a Multi-Ethnic Population in South China

Hearing loss is a common sensory deficit in humans with intricate genomic landscape and mutational signature. Approximately 1 - 3 out of 1,000 newborns have hearing loss and up to 60% of these cases have a genetic etiology. In this study, we conducted the concurrent newborn hearing and genetic screening in 20 mutations in GJB2, GJB3, SLC26A4 and MT-RNR1 for 9,506 normal newborns (4,977 [52.4%] males) from 22 ethnic population in South China. A total of 1,079 (11.4%) newborns failed to pass the initial hearing screening, 160 (23.9%) infants failed to pass the re-screening, and 128 (1.4%) infants presented the diagnostic hearing loss. For the genetic screening, 220 (2.3%) newborns presented at least one of the screened mutations were more likely to fail the hearing screening and have diagnostic hearing loss than mutation negative newborns. In comparison of the differences of distribution of mutations, we did not identify any significant difference in the prevalence of screened mutations

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.